The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Quality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases
Abstract
BACKGROUND: Neurofibromatosis type 1 affects quality of life (QoL) through association with severe complications, impact on cosmetic features, and uncertainty of the effects of the disorder. OBJECTIVE: To evaluate the impact of the severity and visibility of neurofibromatosis type 1 on QoL. DESIGN: Monocenter, cross-sectional study. SETTING: One French academic dermatological and neurofibromatoses clinic. PATIENTS: A total of 128 adult patients with neurofibromatosis type 1. MAIN OUTCOME MEASURES: Evaluation of severity and visibility using, respectively, the Riccardi and Ablon scales. Evaluation of skin disease-specific and general QoL using, respectively, Skindex-France and SF-36 (Short Form 36 health survey) profiles controlled for sex, age, severity, and visibility. RESULTS: In a multiple regression model controlling for sex, age, and visibility, visibility remained independently associated with the alteration of 3 aspects of the skin disease-specific QoL (Skindex-France): emotions, physical symptoms, and functioning (P =.03, P =.009, and P =.002, respectively). Patients with more severe neurofibromatosis reported more effects on the following domains of their general health QoL (SF-36): physical function, bodily pain, general health perception, and vitality (P =.006, P =.03, P =.01, and P =.04, respectively). CONCLUSIONS: Neurofibromatosis type 1 has a significant impact on QoL through alteration of health and appearance. The consequences of visibility and severity from the viewpoint of patients can be evaluated using Skindex and the SF-36, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guillemin, F., Bombardier, C., & Beaton, D. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90142-n · Cited by 6,060
Cited by
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.061 · Cited by 369
Self-citationCritical Review of Generic and Dermatology-Specific Health-Related Quality of Life Instruments
Both, H., Essink-Bot, M.-L., Busschbach, J., & Nijsten, T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701142 · Cited by 327
Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems
Mautner, V.-F., Granström, S., & Leark, R. A. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712450749 · Cited by 39
Metadata
- Authors
- Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplège, A.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-01
- Volume
- 137
- Issue
- 11
- Pages
- 1421-5
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2051465756
- Cited by
- 208
- References
- 1
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases. https://app.cochat.ai/papers/10.1001/archderm.137.11.1421
- The paper
- Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplège, A. (2001). Quality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases. Archives of Dermatology. https://doi.org/10.1001/archderm.137.11.1421
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.